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Abstract
To conduct a systematic review and meta-analysis of longitudinal studies assessing the bi-directional association between
depression and diabetes macrovascular and microvascular complications. Embase, Medline and PsycINFO databases
were searched from inception through 27 November 2017. A total of 4592 abstracts were screened for eligibility. Meta-
analyses used multilevel random/mixed-effects models. Quality was assessed using the Newcastle-Ottawa scale. Twenty-
two studies were included in the systematic review. Sixteen studies examined the relationship between baseline
depression and incident diabetes complications, of which nine studies involving over one million participants were
suitable for meta-analysis. Depression was associated with an increased risk of incident macrovascular (HR = 1.38; 95%
CI: 1.30–1.47) and microvascular disease (HR = 1.33; 95% CI: 1.25–1.41). Six studies examined the association
between baseline diabetes complications and subsequent depression, of which two studies involving over 230 000
participants were suitable for meta-analysis. The results showed that diabetes complications increased the risk of
incident depressive disorder (HR = 1.14; 95% CI: 1.07–1.21). The quality analysis showed increased risk of bias notably
in the representativeness of selected cohorts and ascertainment of exposure and outcome. Depression in people with
diabetes is associated with an increased risk of incident macrovascular and microvascular complications. The
relationship between depression and diabetes complications appears bi-directional. However, the risk of developing
diabetes complications in depressed people is higher than the risk of developing depression in people with diabetes
complications. The underlying mechanisms warrant further research.
Diabet. Med. 36, 1562–1572 (2019)
Introduction
Diabetes is associated with long-term complications includ-
ing microvascular and macrovascular disease. Prospective
studies have also shown a significant bi-directional relation-
ship between Type 2 diabetes and depression [1,2]. Meta-
analytical evidence of longitudinal studies indicates that
diabetes increases the risk of developing depression by
approximately 25% [3,4] and that depression increases the
risk of incident Type 2 diabetes by 40–60% [2,3].
Depression not only increases emotional suffering in
people with diabetes, it is also associated with elevated
prevalence of diabetes complications [5,6]. More specifically,
a meta-analysis of 27 studies focusing on the associations of
depression with macrovascular complications (such as coro-
nary artery disease), microvascular complications (diabetic
retinopathy, neuropathy, nephropathy or end stage renal
disease) and sexual dysfunction found a significant and
consistently positive relationship [7]. Effect sizes (correla-
tions) were small to moderate, ranging from 0.17 to 0.32
(overall effect size of 0.25) and were similar across Type 1
and Type 2 diabetes study samples. However, all of the
included studies had a cross-sectional design, precluding the
identification of directions and pathways. For example,
similar to the longitudinal relationship between depression
and diabetes, depression and diabetes complications may beCorrespondence to: Arie Nouwen. E-mail: a.nouwen@mdx.ac.uk
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related either bi-directionally (depression may increase the
risk of incident diabetes complications and vice versa) or
only uni-directionally.
Since the publication of that meta-analysis, a number of
prospective population-based studies have examined the
longitudinal relationships between depression and diabetes
complications. However, comprehensive analysis of the
magnitude and direction of these relationships is unavailable.
Therefore, the aim was to examine the directional relation-
ships between depression and diabetes macrovascular and
microvascular complications by conducting a systematic
review of longitudinal epidemiological studies. Where pos-
sible, meta-analyses were carried out to quantify the sizes of
the associations.
Methods
Data sources and searches
This study is reported according to the Preferred Reporting
Items for Systematic Reviews and Meta-Analyses (PRISMA)
[8]. Literature searches were conducted using Embase,
Medline and PsycInfo from inception through 27 November
2017, including references of eligible articles. Databases were
searched using Medical Subject Headings (MeSH) and
Boolean operators. The search terms (for Embase see the
supporting information) were adapted to meet the require-
ments of each database.
Study selection
The results of the searches were divided into batches of 500,
and for each batch two authors independently screened the
titles and abstracts. Selected papers were retrieved and two
other authors independently scrutinized the full text papers
for inclusion. Disagreements were resolved by discussion
between the authors and the first author (AN).
Articles meeting the following study criteria were included:
(i) involving adults (>18 years old) at the time of follow-up
with Type 1 or Type 2 diabetes; (ii) published in peer-
reviewed, English language journals; and (iii) examining the
longitudinal relationship between depression and at least one
long-term complication of Type 1 or Type 2 diabetes.
Diabetes complications included microvascular diseases
(retinopathy, neuropathy, nephropathy, sexual dysfunction,
diabetic foot) and macrovascular diseases (angina, stroke,
coronary artery disease, myocardial infarction, peripheral
vascular disease). Studies solely focusing on amputations
related to diabetes complications (n = 7) and studies
examining the relationship between depression, diabetes
and cardiovascular mortality were not included as these
have been the topic of recent systematic review/meta-
analyses [9,10]. Moreover, amputations reflect treatment
decisions, which may confound their relationship with
depression. Studies were also excluded if they focused on
gestational diabetes, impaired glucose tolerance or pre-
diabetes. Studies examining the relationship of diabetes
complications with either lifetime or current depression were
included.
Data extraction and quality assessment
One author (AN) performed data extraction, which was
verified by two other authors (MCA, MMI). Data of interest
included: (i) name of first author; (ii) publication year; (iii)
country; (iv) study design; (v) number of participants; (vi)
mean age/age range; (vii) gender; (viii) diabetes type; (ix)
diabetes duration; (x) follow-up length; (xi) depression
assessment method; (xii) diabetes assessment method; (xiii)
diabetes complications assessment method; and (xiv) results
regarding associations between depression and diabetes
complication(s).
Method of depression assessment could be either a
diagnosis of depression assessed by a diagnostic psychiatric
interview or assessment of depressive symptoms using a self-
report questionnaire. Type of diabetes and diabetes compli-
cations could be assessed either via self-reporting or
extracted from medical records. Diabetes complications
could be assessed via self-reporting, with the use of diagnos-
tic tests, or extracted from medical records.
Quality assessment of included studies was conducted by
two authors (AN, KvD) based on the Newcastle-Ottawa
scale [11] for cohort studies. Three domains were evaluated
for each study: selection of the study groups, comparability
of the groups and ascertainment of outcome of interest
(Table 1). There were three levels of evidence: low risk of
bias (a score of 7–9), moderate risk of bias (5–6) and a high
risk of bias (score < 5) [12].
What’s new?
• Numerous studies have examined the longitudinal
relationship between depression and diabetes compli-
cations but comprehensive evidence about the magni-
tude and direction is unavailable.
• The current study shows that the relationship between
depression and diabetes complications appears bi-
directional with depression being associated with an
increased risk of developing incident macrovascular and
microvascular complications, and diabetes complica-
tions increasing the risk of subsequent depression.
• The increase in risk of developing diabetes complica-
tions in depressed people (by 38 and 33% for
macrovascular and microvascular complications,
respectively) is higher than the increase in risk of
developing depression (by 9 and 24% for macrovascu-
lar and microvascular complications, respectively) in
people with diabetes complications.
ª 2019 Diabetes UK 1563
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Data synthesis and analysis
The meta-analysis used multilevel random/mixed-effects
models with random effects for studies and estimates within
studies, which accounts for the dependency in the underlying
true effects for studies supplying multiple estimates (in some
studies, the same participants were assessed for multiple
macrovascular and microvascular outcomes). Although cor-
relation in the sampling errors is not automatically consid-
ered in this model, theoretical considerations and simulation
studies [13] have shown that the multilevel model automat-
ically subsumes this source of dependency into the correla-
tion between the true effects and therefore provides valid
inferences about the fixed effects. As a sensitivity analysis, we
also used cluster-robust inference methods, [13–15] which
yielded identical conclusions.
Criteria for meta-analysis were outcomes reported as
proportional HRs and 95% CIs. For some studies, to obtain
the estimate of interest (e.g. reference group people with
diabetes and no depression vs. people with diabetes and
depression) we recalculated HRs using the procedures
described in Van Dooren et al [9]. For Black et al. [16] we
combined the HRs for the group of participants with diabetes
without any depressive symptoms (Center for Epidemiologic
Studies Depression Scale = 0) and those with diabetes with
minimal depression (Center for Epidemiologic Studies
Depression Scale = 1–15) into the reference group. For Lin
et al. [17] we combined the groups with probable minor
depression (Patient Health Questionnaire-9 algorithm) and
no depression into the reference group and compared them
with the group with probable major depression
(Patient Health Questionnaire-9 algorithm). For Scherrer
et al. [18] we used the information from the four-group
scenario (neither diabetes nor major depressive disorder,
major depressive disorder alone, Type 2 diabetes alone, and
co-morbid major depressive disorder and Type 2 diabetes) to
obtain the HRs for the comparison of the two diabetes
groups. For the meta-analyses, all outcome variables were
dichotomized.
Results
Search results
Figure 1 shows the results of the selection process. The
searches yielded 7457 potential articles. After removing
conference papers, books, dissertation abstracts and dupli-
cates within or between the databases, 4591 abstracts
remained. Twenty-nine eligible papers were selected, 24
from Embase and 5 additional papers from Medline (no
additional papers from PsycInfo). One of the authors
identified an additional paper [19] not included in the search
results, bringing the total to 30 papers. Searches of the
reference lists did not identify additional potential papers.
The extracted data of the 30 studies are presented in
Table S1A-C.
Where more than one study relied on the same cohort (six
papers from the Epidemiological Diabetes Cohort study [20–
25] and four from the Pathways Epidemiological study
[17,26–28]), only the most recent or the most complete study
[17,23] was selected for the review, resulting in 22 papers
being included in the systematic review. Of those, 16 papers
(including 1025 563 people with diabetes) examined the
relationship of depression to incident diabetes complications
(Table S1A,B) while 6 papers (including 239 519 people with
diabetes) examined the relationship of diabetes complica-
tions to incident depression (Table S1C). Data came
predominantly from the USA but also from Canada, China,
Italy, Norway, Taiwan, Germany, the UK and The Nether-
lands.
Three of the 22 studies examined people with Type 1
diabetes, [23,29,30] nine examined people with Type 2
diabetes, [16–19,31–35] and 6 examined people with either
Type 1 or Type 2 diabetes [36–41]. Four studies did not
specify the type of diabetes [42–45].
Twelve studies quantified the results in terms of Cox
proportional HRs, [16–19,31–33,36,38,41,42,45] while
others used ORs, [29,30,35,40,43,44] RR [37], or provided
regression coefficients [39]. Two papers briefly explained
that depression did not increase incident diabetes complica-
tions but neither provided numerical data [23,34]. Of the 12
studies reporting Cox proportional HRs, 10 concerned
depression as a risk factor for the onset of diabetes
complications and 2 concerned the relationship from dia-
betes complications to incident depression.
Depression as a risk factor for diabetes complications
Nine of the 10 studies reporting HRs and 95% CI were
suitable for meta-analysis; one study was not suitable for
inclusion because a continuous depression measure was used
rather than dichotomized depression [41]. Nine studies
allowed for a meta-analysis testing depression as a risk
factor for macrovascular disease. Four of the nine studies
provided data on depression as a risk factor for microvas-
cular complications, which could be used in an additional
meta-analysis. Of the nine studies [16–19,31,32,36,38,45],
most used a composite macrovascular outcome including
conditions such as myocardial infarction, coronary artery
disease, congestive heart failure and stroke, but some also
included cardiovascular procedures (e.g. percutaneous coro-
nary artery intervention, coronary artery bypass grafting,
abdominal aortic aneurysm repair and revascularization of
the lower extremity [16]) or unstable angina [31] to obtain a
single estimate of macrovascular disease. However, one
study [36] reported separate outcomes for stroke and coro-
nary heart disease for the same sample, which were included
individually.
ª 2019 Diabetes UK 1565
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Of the four studies also analysing microvascular compli-
cations [16,17,31,36], three included a composite microvas-
cular outcome [16,17,31], while Novak et al. [36] only used
incident chronic kidney disease as an outcome.
To examinewhether theHRsof developing complications in
people with diabetes and depression differed according to the
type of complication (macro/micro), we first carried out a
moderator analysis. The results showed that the relationship
between depression and complication development did not
differaccording to typeofcomplication [v2(1)=0.67,P=0.41],
allowing us to analyse an overall measure of complications.
In this initial analysis, those with depression were on
average 51% more likely to develop a complication than
those without depression (HR = 1.51; 95% CI: 1.23–1.86). A
forest plot of the HRs and 95% CI of each study, together
with the estimated overall HR based on all estimates
combined, is shown in Figure 2.
However, there was considerable heterogeneity between
studies [Cochran’s Q (13) = 92.30, P < 0.001; I2 = 86%].
Standardized residuals and Cook’s distances showed that
Black et al. [16] was an influential study and the source of the
heterogeneity in these data (primarily due to a much larger
effect size than other studies formicrovascular disorders). This
study was also the only one in the initial meta-analysis where
complications were based on self-reporting; therefore, we
repeated the above analyses without its inclusion, and regard
those secondary results as our study’s primary findings.
Moderator analysis of complication type was significant
for these 11 studies [v2 (1) = 18.82, P < 0.001]; therefore,
results are reported separately for macrovascular and
Records identified through database 
searching
(n = 7457)
Additional records identified 
through other sources
(n = 1)
Conference papers, 
books, dissertations, 
duplicates removed
(n = 2866)
Records excluded
(n = 4493)
Full-text articles assessed for 
eligibility
(n = 99)
Full-text articles excluded with reasons
(n = 69)
Not focused on diabetes population (n = 23)
Not focused on diabetes complications (n =
10)
Outcome = recurrent foot ulcers (n = 2)
Outcome = cognitive decline/dementia (n = 4)
Outcome = mortality (n = 5)
Other outcomes (n = 7)
No comparison of complications vs. no 
complications (n = 3)
Cross-sectional (n = 12)
Participants were adolescents (n = 1)
Complications to persistent depression (n = 2)
Studies from the same cohort 
with duplicate information 
(n = 8)
Epidemiology of Diabetes 
Complication (EDC) (n = 5)
Pathways (n = 3)
Studies identified
(n = 30)
noitacifitnedI
ytilibigilE
gn ineer cS
noisulcnI
Records identified 
through Embase
(n = 4885)
Records identified 
through PsycInfo
(n = 943)
Records identified 
through Medline
(n = 1629)
Studies included
(n = 22)
depression -> complications (n = 16)
complications -> depression (n = 6)
Studies included in the meta-
analyses (n = 11) 
Depression -> complications (n = 9)
Complications -> depression (n = 2)
Studies not included in the meta-
analyses (n = 11) 
Depression -> complications (n = 7)
Complications -> depression (n = 4)
Records screened
(n = 4591)
FIGURE 1 Flowchart of study selection process.
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microvascular complications. Depression was associated
with an increased risk of macrovascular (HR = 1.38; 95%
CI: 1.30–1.47) and microvascular (HR = 1.33; 95% CI:
1.25–1.41) complications (Figure 2). Sensitivity analyses
using the cluster-robust inference approach yielded identical
conclusions in all of the analyses reported above.
A number of studies (n = 7) identified in the systematic
review reported incompatible statistics and could not be
included in the meta-analysis (e.g. ORs instead of HRs; for
full details, see Table S1). In terms of macrovascular
complications, the results of two studies supported the
findings of the meta-analysis [29,35]. Another study[23]
found a significantly increased risk only for angina (HR =
1.40; 95% CI: 1.06–1.84), but not for the objective,
coronary artery disease (no statistics were provided for the
latter). In terms of microvascular complications, results were
mixed, with three studies supporting [30,41,43] and two
failing to support the findings of the meta-analysis [34,35].
Regarding incident foot ulcers, one study found that there
was a linear relationship between increased risk and the
severity of depressive symptoms [43].
Diabetes complications as a risk factor for depression
Six studies examined the hypothesis that diabetes complica-
tions increase the risk of incident depression
[33,37,39,40,42,44]. For the two largest of these studies
(combined N = 234 628), nine HRs of diagnosed depression
were suitable for meta-analysis [33,42]. Therefore, we tested
whether any diabetes complication increased the risk of
incident depressive disorder. Results showed that diabetes
complications increased the risk of incident depressive
disorder (HR = 1.14; 95% CI: 1.07–1.21). Analysis using
the cluster-robust approach confirmed these results. Because
moderator analysis of complication type was significant [χ2
(1)=3.91, p = .048], we report the results of the meta‐analysis
separately for macrovascular and microvascular complica-
tions. Both macrovascular complications (HR = 1.09; 95%
FIGURE 2 Forest plot of HRs of longitudinal studies included in the meta-analysis examining associations from baseline depression to incident
diabetes complications, grouped by macrovascular complications and microvascular complications. Abbreviations: CAD, coronary artery disease;
CHD, coronary heart disease; CVD, cerebrovascular disease; MI, myocardial infarction; PVD, peripheral vascular disease.
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CI: 1.02–1.17) and microvascular complications (HR=1.24;
95% CI: 1.12–1.37) were associated with an increased risk of
depressive disorder. For a Forest plot of these results, see
Figure 3.
The remaining four studies [37,39,40,44] reported statis-
tics that were incompatible with their inclusion in the meta-
analysis (e.g. ORs or RRs instead of HRs; for full details, see
Table S1C). One study[44] found that diabetes complications
(not specified) increased the odds of developing depressive
symptoms (OR = 1.46; 95% CI 1.14–1.86). The results of the
three studies that did examine specific diabetes complications
mirrored those of the two studies in the meta-analyses.
Regarding macrovascular complications, one study[37]
found an increased risk of depressive symptoms with
coronary artery disease, cerebral vascular disease and
peripheral vascular disease, while another study[40] found
this to be the case for macrovascular events or procedures,
but not for stroke. Regarding microvascular complications,
one study[40] found no significantly increased risk of
depressive symptoms with either retinopathy or nephropa-
thy. Two other studies [37,39] found an increased risk of
depressive symptoms with neuropathy, but not with
retinopathy or foot problems [37]. (For further details, see
Table S1C).
Quality of evidence
Of the 22 included studies, 2 showed a high risk of bias, 8
showed a moderate risk of bias and 12 showed a low risk of
bias (Table 1). Risk of bias was mainly due to the use of
selected rather than representative cohorts (8 of 22 studies),
use of self-reporting or failure to report the use of secure
records or structured interviews to ascertain exposure (15 of
22 studies) or outcome (9 of 22 studies), and failure to
demonstrate that the outcome of interest (diabetes compli-
cations/depression) was not present at baseline (10 of 22
studies, although all but 3 studies [35,38,45] statistically
controlled for this).
Discussion
This systematic review identified nine studies suitable for
meta-analysis which showed that in people with diabetes,
those with co-morbid depression have a 38 and 33%
increased risk of developing macrovascular and microvascu-
lar complications, respectively, compared with controls
without depression. Eight studies were identified as unsuit-
able for inclusion in the meta-analysis. For macrovascular
complications, the results of these studies generally
FIGURE 3 Forest plot of HRs of longitudinal studies included in the meta-analysis examining associations from baseline diabetes complications,
grouped by macrovascular and microvascular complications, to incident depression. Abbreviations: CHD, coronary heart disease; CVD,
cerebrovascular disease; MI, myocardial infarction; PVD, peripheral vascular disease.
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concurred with those obtained in the meta-analysis, except
for one [23]. For microvascular complications, results were
mixed, with three supporting [30,41,43] and two failing to
support[34,35] the findings of the meta-analysis. Of the
latter, one examined participants during their first two years
of newly diagnosed diabetes [35], and the other had cognitive
function as the main predictor variable [34].
Finally, six identified studies examined the relationship
from diabetes complications to incident depression
[33,37,39,40,42,44]. In the meta-analysis of the two largest
studies [33,42] (total N = 234 628), diabetes complications
increased the risk of developing depressive disorder by 14%.
Although this increase in risk was found to be higher for
microvascular than for macrovascular complications (by 24
vs. 9%, respectively), because of the small number of studies
these results should be interpreted with caution. The results of
the six studies not included in the meta-analyses (Table S1C)
mimic those of the meta-analysis and suggest that having
macrovascular andmicrovascular diabetes complicationsmay
increase the risk of developing depression. However, across
the six studies examining the relationship of diabetes compli-
cation as a risk factor for depression, we did not find evidence
of a systematic effect of specific complications.
Taken together, our results provide support for a bi-
directional relationship between diabetes complications and
depression. In other words, depression (both depressive
symptoms and major depressive disorder) increases the risk
of incident macrovascular and microvascular diabetes com-
plications, and the presence of diabetes complications
increases the risk of significant depressive symptoms and/or
possible depressive episode. However, the increase in risk of
developing diabetes complications (by 38 and 33% for
macrovascular and microvascular complications, respec-
tively) in depressed people is higher than the increase in risk
of developing depression (by 9 and 24% for macrovascular
and microvascular complications, respectively) in people
with diabetes complications. These findings parallel those
found for the bi-directional longitudinal relationships
between diabetes and depression with a modest increased
relative risk (15%) of developing depression in people with
diabetes and a higher relative risk (60%) for the development
of diabetes in depressed people [2].
These findings may reflect different underlying mecha-
nisms for the relationship from depression to diabetes or
diabetes complications than for the relationship from
diabetes or diabetes complications to depression. While the
exact nature of these underlying mechanisms remains
unknown, there are a number of common processes that
may result in these negative outcomes. First, depression is
often accompanied by behavioural changes, including
reduced self-care and medication adherence [46], increased
smoking, reduced physical activity and increased sedentary
behaviours, and increased intake of high-calorie food [47].
These behaviours may be particularly problematic in the
context of diabetes and are likely to adversely affect
glycaemic control, which, in turn, is associated with
increased risk of complications[48]. Moreover, the UK
Prospective Diabetes Study has shown that a 1% in reduction
in HbA1c may delay the onset of diabetes complications by
21% [49]. However, research found no evidence that
depression delays insulin initiation [50,51].
More recently, biological processes associated with obe-
sity, insulin resistance and persistently poor glucose control,
have been implicated in the development of diabetes com-
plications in the context of depression. More specifically,
inflammatory processes associated with both diabetes and
depression [52] have been identified as possible mechanisms
[53]. Other studies have shown that depression and diabetes
are associated with endothelial function, increasing the risk
of macrovascular disease [54], although the underlying
mechanisms have yet to be elucidated.
The mechanisms underlying the increased risk of incident
depression as a result of diabetes complications are likely to
be similar to those hypothesized for diabetes as a risk for
depression onset. Although inflammation and other biolog-
ical factors may play a role [52,54], the epidemiological
evidence points to the role of diabetes burden and distress as
contributing factors [55,56]. The results of our study,
showing no systematic effect of specific diabetes complica-
tions, is consistent with the latter. It should be noted that
only one study[39] examining the relationship of complica-
tions with incident depression controlled for pain as a
possible contributor.
Overall, the results of the current study extend the findings
of a previous systematic review/meta-analysis of cross-
sectional studies [7] and shows that depression is associated
with an increased risk of diabetes complications. Impor-
tantly, given that depression is a treatable condition, the
clinical implication of this study is that depression could be a
preventable risk factor for diabetes complications. Future
studies are needed to examine whether intensive and
successful treatment of depression in diabetes does indeed
reduce the risk of future complications [57].
The current study also adds to an increasing number of
longitudinal studies showing that depression in diabetes,
even when using self-report questionnaires, can have serious
consequences, including reduced self-care [39], increased
cognitive decline [58], dementia [59] and mortality [9].
A number of limitations should be taken into consider-
ation when interpreting the results of this study. First,
despite the large number of participants upon which the
meta-analyses were based, the relatively small number of
studies available (n = 9 for the relationship from depression
to diabetes complications and n = 2 for the relationship
from diabetes complications to depression) precluded exam-
ination of the contribution of factors such as specific
diabetes complications, type of depression measurement,
and type of diabetes. Moreover, although some studies
included participants with Type 1 diabetes with paediatric
onset, teasing out the effects of depression on diabetes
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complications in Type 1 vs. Type 2 diabetes remains a topic
for future research.
Second, the quality assessment of the included studies
found a high risk of bias in two studies due to, among other
factors, the use of self-report measures to ascertain exposure
or outcome. Self-reporting should be avoided when objective
diagnostic tests are available, such as in the case of diabetes
complications. However, as there are no known biomarkers
for depression, its assessment remains based on symptoma-
tology; although structured diagnostic interviews are con-
sidered the gold standard for identifying depression, self-
report symptom questionnaires are commonly used. While
the use of such questionnaires may be regarded as introduc-
ing bias, research suggests that symptom questionnaires and
diagnostic interviews assess different constructs, with ele-
vated depressive symptoms more reflective of general and
diabetes-specific emotional distress than of clinical depres-
sion [60]. Furthermore, although most studies provided
follow-up data, only a few studies provided information as
to how many people had died from diabetes complications
during the follow-up period. Because mortality is higher in
people with depression, it is likely that the results from the
meta-analysis are conservative. Third, the included studies
did not provide information regarding the specific set of
complications individuals developed during the study. It is
therefore impossible to ascertain whether depression leads to
the development of only single complications or a cluster of
complications. Furthermore, some of the studies in the meta-
analysis[17,31,32,36] included not only diabetes complica-
tions but also surgical interventions, which may or may not
have resulted from the onset or worsening of diabetes
complications and may have confounded the observed
relationships. Fourth, it is unclear how clinical management,
access to medical care, disease management supplies and
medications, financial burden of diabetes, and other socio-
economic factors play into the development of depression or
diabetes complications and the relationship between the
two.
In summary, depression in people with diabetes is associ-
ated with an increased risk of incident macrovascular and
microvascular complications. This relationship is likely to be
bi-directional as diabetes complications were also found to
increase the risk of incident depression. It remains to be
determined whether effective treatment of depression reduces
the risk of developing diabetes complications.
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